Sechenov School
Home › Pharmacology › Effects of Medications on the Fetus

Effects of Medications on the Fetus

For medical students2 min readUpdated 2026-10-10

During pregnancy, the developing organism is exceptionally vulnerable to drug exposure. The nature and severity of damage directly depend on the specific gestational age, manifesting as mutagenic, embryotoxic, teratogenic, or fetotoxic effects.

Critical periodThe first trimester, especially weeks 4–8, is the most hazardous for active organogenesis.
All-or-noneDuring weeks 1–3, the embryo exposed to toxins either dies or develops normally.
MutagenicityDamage to the genetic apparatus of cells occurring even before conception.
Hazardous drugsAntimetabolites, antimitotic agents, methotrexate, and thalidomide are in the high-risk group.

Pre-conception and Early Pregnancy Impacts

The negative impact of toxic substances can begin long before actual pregnancy occurs. Mutagenic action is characterized by direct damage to the genetic apparatus (DNA). This effect impacts the germ cells of the partners before conception and may also extend to somatic cells.

Upon successful fertilization, the period of potential embryotoxic action begins (derived from the Greek word embryon, meaning 'germ' or 'embryo'). This type of toxic influence spans the first twelve weeks of the first trimester, but its specificity is most pronounced in the earliest stages—from the first to the third week of pregnancy.

During this timeframe, corresponding to the blastocyst stage, the fertilized egg (zygote) is located within the lumen of the fallopian tubes and uterine cavity until implantation is complete. Drug exposure during this period follows the strict 'all-or-none' principle: gross developmental disruptions inevitably lead to embryonic death, or, if damage is avoided, the embryo continues to develop absolutely normally. Drugs with proven embryotoxic effects include antimitotic agents (e.g., colchicine) and antimetabolites (mercaptopurine, fluorouracil).

Teratogenic Action and Organogenesis Impairment

The term teratogenic action originates from the Greek root teras, meaning 'monster' or 'malformation'. This effect represents a gross disruption of organ and system formation—organogenesis. As a result of such interference, severe congenital skeletal malformations and major anomalies in the internal organs of the embryo arise.

The physiological context of this phenomenon is that the critical period for teratogenic effects occurs between the third and twelfth weeks, with the absolute peak of danger at weeks 4–8 of pregnancy. It is during this temporal window that internal organs actively develop and skeletal elements form, making embryonic tissues maximally susceptible to damaging factors.

The high-risk group includes antineoplastic agents, specifically folic acid antagonists (a typical representative is methotrexate). Special attention should be paid to ethanol: its consumption is extremely hazardous, especially if it coincides with the moment of conception.

Historical Example: The Thalidomide Tragedy

The most famous, large-scale, and tragic example of delayed delayed embryotoxic catastrophe (type D) was the 'thalidomide disaster', which unfolded between 1956 and 1962.

The drug thalidomide was widely prescribed to pregnant women in early pregnancy as an effective antiemetic and sedative (sleeping aid) agent. Its use spanned Western Europe, the Americas, and Australia. The consequence of taking this medication was the birth of many children with specific congenital limb malformations.

This pathology received the medical name phocomelia (derived from the Greek words phoke meaning 'seal', and melos meaning 'limb' or 'body part'). In phocomelia, a child's arms and legs remain underdeveloped and visually resemble seal flippers.

Fetotoxic Action in Later Stages

As the critical first trimester and basic formation of all anatomical structures conclude, the fetal period begins. It starts after the twelfth week of pregnancy and continues until delivery.

The negative impact of medications at this stage is classified as fetotoxic action. Its key distinction is the absence of gross anatomical malformations, as the fetal organs have already formed. Instead, drugs provoke functional disruptions of organ systems or significantly impair the maturation processes of fully formed fetal organs.

Mnemonic

Chronological rule 'METF': Mutagenic (pre-conception) → Embryotoxic (1–3 wks) → Teratogenic (3–12 wks) → Fetotoxic (12 wks to delivery).

Frequently asked questions

Which pharmacological groups and drugs have embryotoxic action?

Antimetabolites, antimitotic agents, certain antiviral drugs, and anticoagulants possess embryotoxic action. Drugs with proven or potential embryotoxic effects leading to severe developmental disruption or embryonic death include:

  • Antimetabolites — mercaptopurine, fluorouracil.
  • Antimitotic agents — colchicine.
  • Antivirals — ribavirin.
  • Anticoagulants — warfarin.
Which drugs possess teratogenic action?

A wide spectrum of medications from various pharmacological groups possesses teratogenic action. Drugs causing developmental anomalies include:

  • Sedatives/Hypnotics — thalidomide.
  • Antineoplastics and immunosuppressants — methotrexate, cyclophosphamide, mycophenolate mofetil, leflunomide.
  • Antihypertensives — ACE inhibitors (lisinopril, captopril, benazepril, enalapril) and ARBs (losartan, valsartan, candesartan).
  • Psychotropic drugs — lithium salts (Lithium).
  • Vitamins — retinoids (Retinoids), isotretinoin.
  • Antimicrobials and antivirals — streptomycin, ribavirin, efavirenz, pyrimethamine + sulfadiazine combination.
  • Antiepileptics — carbamazepine.

Ethanol also exerts a teratogenic effect.

Which medications cause fetotoxic action?

Fetotoxic action is caused by drugs that disrupt the function or maturation of already formed fetal organs in late pregnancy. Such medications include:

  • Anticoagulants (including warfarin) — carry a risk of bleeding in the newborn due to reduced clotting.
  • Sulfonylureas — provoke a risk of fetal hypoglycemia.
  • Neurotropic substances (alcohol, illicit drugs, sedatives) — lead to depression of the fetal central nervous system.
What pregnancy risk categories for drug use are designated by the FDA?

The FDA pregnancy risk categories are:

CategorySafety ProfileExamples
ASafety provenPotassium chloride, iron supplements
BRelatively safeInsulin, acetylsalicylic acid, metronidazole
CPotential risk; use if benefits justify risks—
DProven risk; use in life-threatening situations if benefits outweigh risksDiazepam, efavirenz
XAbsolutely contraindicatedIsotretinoin, carbamazepine, streptomycin

Category N indicates unclassified drugs; an example is elsulfavirine.

What is the core of the 'all-or-none' principle in embryotoxic action?

It means that toxic drug exposure at the blastocyst stage (1–3 weeks) either causes gross damage leading to embryonic death or leaves no consequences, and further development proceeds completely normally.

At what gestational age are tissues most sensitive to teratogens?

Tissues exhibit maximal sensitivity to damaging factors during active organogenesis—at weeks 4–8 of pregnancy (within the first trimester).

How does fetotoxic action differ from teratogenic action?

Teratogenic action disrupts organ formation (causing malformations) in the first trimester. Fetotoxic action occurs in the fetal period (after 12 weeks) and disrupts only the function or maturation of already formed organs.

Go deeper

More topics in Pharmacology

Isosorbide DinitrateAlkylating Agents: Mechanism, Types, and ToxicityMucolytic AgentsPassive DiffusionIonotropic ReceptorsRepeated Drug Administration: Cumulation, Tolerance and SensitizationOpioid Analgesics: Mechanism of Action and PharmacologyNSAID Side Effects: Mechanisms & Clinical ComplicationsNicotinic Acetylcholine ReceptorsPharmacology of BenzodiazepinesCOMT InhibitorsAbciximab: Mechanism, Structure and Clinical UsePharmacology →